Year: 2024
Type: article
Abstract: chemotherapy, targeted therapy, monoclonal antibodies, tyrosine kinase inhibitors, conjugated monoclonal antibodies, resistance to anticancer therapy.
Source: Practical oncology
DOI: 10.31917/2504303
Authors: S.А. Tjulandin, O.А. Kuznetsova
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W4408291098
